According to the Florida Department of Health, flu cases and emergency visits have been increasing across the state. In ...

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...

You hear about the flu vaccine, the COVID-19 vaccine, even the pneumonia vaccine, but in 2023, the FDA approved the first RSV ...

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...